News on Novo

18 days ago

Share

There has been 12 news on Novo in the past from 6 sources across 2 sections.

Access to all news on this scope:

See the trend on this scope:

Evolution through time

Sentiment analysis

Current sentiment polarity: neutral with a score of 0

Sentiment polarity through time

Latest news

Click on the source to read the entire article:

Shortage of Novo's Wegovy and Ozempic is resolved, FDA website shows

18d ago

Watch Healthcare Equity Strategist on Novo Setback

80d ago

Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand?

The Wall Street Journal

113d ago

Novo CEO to blame drug middlemen

168d ago

Novo's Wegovy Puts a Higher Price on Heart Health in the US

172d ago

Lilly Gains in Obesity Race With Novo as Supplies Expand

215d ago

Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says

225d ago

Novo Won't Meet Wegovy Demand in Short-Medium Term: CFO

313d ago

Wegovy maker Novo inks $16.5 billion acquisition of Catalent to boost supply

400d ago

Why Obesity Drug Coverage Doesn't Matter (Yet) for Lilly and Novo

The Wall Street Journal

405d ago

Lilly trades at a premium to Ozempic maker Novo as obesity drugs boom. Here's why, analyst says

486d ago

Catalent's Indiana plant to make Novo's Wegovy weight-loss drug

563d ago

Sections

The coverage spans across 2 sections:

business	67%
health	33%

Sources

There has been 6 news sources reporting on this, including: Bloomberg (33%), CNBC News (25%), The Wall Street Journal (17%), The Hill (8%), and Reuters (8%).

Going further

Stay up to date:

Details

This content is available under the CC BY 4.0 license.